Myomo (MYO) Shares Outstanding (2016 - 2025)
Myomo (MYO) posted Shares Outstanding (Entity) of $38.5 million for Q4 2025, little changed on a QoQ basis from $38.4 million in Q3 2025, and up 11.91% year-over-year from $34.4 million in Q4 2024.
Myomo (MYO) Shares Outstanding (2016 - 2025) Analysis & Trends
Myomo's Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $38.5 million for Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 11.91% year-over-year to $38.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38.5 million (up 11.91% YoY) and the FY2025 annual result came in at $38.5 million, up 11.91% from the prior year.
- Shares Outstanding (Entity) was $38.5 million for Q4 2025 at Myomo, roughly flat from $38.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $38.5 million in Q4 2025 and bottomed at $5.6 million in Q1 2021.
- A 5-year average of $22.6 million and a median of $27.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 400.02% — and 2025, when it slipped 6.3%.
- Myomo's Shares Outstanding (Entity) stood at $6.9 million in 2021, then increased by 12.82% to $7.8 million in 2022, then jumped by 250.1% to $27.1 million in 2023, then gained by 26.69% to $34.4 million in 2024, then rose by 11.91% to $38.5 million in 2025.
- Business Quant data shows MYO's Shares Outstanding (Entity) at $38.5 million in Q4 2025, $38.4 million in Q3 2025, and $37.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 42.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.17 Mn |
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 37.76 Mn |
| Sep 30, 2024 | 37.95 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 36.75 Mn |
| Dec 31, 2023 | 29.50 Mn |
| Sep 30, 2023 | 35.27 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.92 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 5.83 Mn |
| Sep 30, 2021 | 5.68 Mn |
| Jun 30, 2021 | 5.64 Mn |
| Mar 31, 2021 | 5.19 Mn |